{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:01:54Z","timestamp":1776103314204,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Understanding perception and communication gaps between patients with neurological diseases and their treating physicians is essential for optimizing patient-centered care. The GAP-AI study aimed to identify these gaps in a cohort of patients with Parkinson\u2019s disease, multiple sclerosis, or epilepsy. This single-center observational study involved patients (N\u2009=\u2009197) and their treating physicians (N\u2009=\u200912) answering questionnaires (18-item Patient Satisfaction Questionnaire Short Form, 9-item Shared Decision Making Questionnaire for patients and physicians, Barthel Index, and 36-item Short Form subdomains) over two clinic visits. The primary outcome was the difference between pairwise items in the questionnaires (perception gap). Perception gaps, albeit minimal, were identified for patient satisfaction, shared decision-making, activities of daily living, and quality of life. Attributes that significantly influenced perception gaps included physician\u2019s age, years of experience\/holding a neurologist qualification, disease area, and the number of patients treated, with experienced physicians tending to provide more rigorous evaluations than their patients\u2019 self-assessments. Multiple machine learning algorithms were used to develop predictive models based on study data. The k-nearest neighbors algorithm demonstrated the best performance in predicting a patient\u2013physician perception gap. Insights from our study highlight the potential to recognize, predict, and ultimately address these gaps, thus enhancing clinical practice by increasing the level of understanding between patients and their physicians.<\/jats:p>","DOI":"10.1038\/s41598-025-33500-x","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:39:40Z","timestamp":1770633580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of perception gaps between physicians and patients with neurological diseases and the prediction of these gaps using machine learning"],"prefix":"10.1038","volume":"16","author":[{"given":"Genko","family":"Oyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Tsunemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuko","family":"Nojiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Sako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Oji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayami","family":"Okuzumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Haginiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Izutsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"33500_CR1","doi-asserted-by":"publisher","first-page":"e0215384","DOI":"10.1371\/journal.pone.0215384","volume":"14","author":"MJ Armstrong","year":"2019","unstructured":"Armstrong, M. J., Rastgardani, T., Gagliardi, A. R. & Marras, C. Barriers and facilitators of communication about off periods in Parkinson\u2019s disease: Qualitative analysis of patient, carepartner, and physician interviews. PLoS ONE 14, e0215384 (2019).","journal-title":"PLoS ONE"},{"key":"33500_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1684\/epd.2015.0751","volume":"17","author":"E Beghi","year":"2015","unstructured":"Beghi, E., Giussani, G. & Sander, J. W. The natural history and prognosis of epilepsy. Epileptic Disord. 17, 243\u2013253 (2015).","journal-title":"Epileptic Disord."},{"key":"33500_CR3","doi-asserted-by":"publisher","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","volume":"16","author":"A Doshi","year":"2016","unstructured":"Doshi, A. & Chataway, J. Multiple sclerosis, a treatable disease. Clin. Med. (Lond). 16, s53\u2013s59 (2016).","journal-title":"Clin. Med. (Lond)."},{"key":"33500_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JPD-202346","volume":"11","author":"RJ Port","year":"2021","unstructured":"Port, R. J. et al. People with Parkinson\u2019s disease: What symptoms do they most want to improve and how does this change with disease duration?. J. Parkinsons Dis. 11, 715\u2013724 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"33500_CR5","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn, G. et al. Shared decision making: A model for clinical practice. J. Gen. Intern. Med. 27, 1361\u20131367 (2012).","journal-title":"J. Gen. Intern. Med."},{"key":"33500_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fpubh.2019.00384","volume":"7","author":"C Lu","year":"2019","unstructured":"Lu, C., Li, X. & Yang, K. Trends in shared decision-making studies from 2009 to 2018: A bibliometric analysis. Front. Public Health 7, 384 (2019).","journal-title":"Front. Public Health"},{"key":"33500_CR7","first-page":"CD001431","volume":"4","author":"D Stacey","year":"2017","unstructured":"Stacey, D. et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 4, CD001431 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"33500_CR8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbmt.2017.03.015","volume":"23","author":"A Barata","year":"2017","unstructured":"Barata, A. et al. Do patients and physicians agree when they assess quality of life?. Biol. Blood Marrow Transplant. 23, 1005\u20131010 (2017).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"33500_CR9","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/archinternmed.2010.239","volume":"170","author":"DP Olson","year":"2010","unstructured":"Olson, D. P. & Windish, D. M. Communication discrepancies between physicians and hospitalized patients. Arch. Intern. Med. 170, 1302\u20131307 (2010).","journal-title":"Arch. Intern. Med."},{"key":"33500_CR10","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.3399\/bjgp15X687637","volume":"66","author":"J Burt","year":"2016","unstructured":"Burt, J., Lloyd, C., Campbell, J., Roland, M. & Abel, G. Variations in GP-patient communication by ethnicity, age, and gender: Evidence from a national primary care patient survey. Br. J. Gen. Pract. 66, e47\u2013e52 (2016).","journal-title":"Br. J. Gen. Pract."},{"key":"33500_CR11","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2147\/NDT.S196930","volume":"15","author":"N Hermanowicz","year":"2019","unstructured":"Hermanowicz, N., Castillo-Shell, M., McMean, A., Fishman, J. & D\u2019Souza, J. Patient and physician perceptions of disease management in Parkinson\u2019s disease: Results from a US-based multicenter survey. Neuropsychiatr. Dis. Treat. 15, 1487\u20131495 (2019).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"33500_CR12","first-page":"1599477","volume":"2021","author":"H Ogura","year":"2021","unstructured":"Ogura, H. et al. Evaluation of motor complications in Parkinson\u2019s disease: Understanding the perception gap between patients and physicians. Parkinson\u2019s Dis. 2021, 1599477 (2021).","journal-title":"Parkinson\u2019s Dis."},{"key":"33500_CR13","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1111\/ene.14432","volume":"27","author":"D Schriefer","year":"2020","unstructured":"Schriefer, D., Haase, R., Ettle, B. & Ziemssen, T. Patient- versus physician-reported relapses in multiple sclerosis: Insights from a large observational study. Eur. J. Neurol. 27, 2531\u20132538 (2020).","journal-title":"Eur. J. Neurol."},{"key":"33500_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3389\/fneur.2017.00729","volume":"8","author":"MC Ysrraelit","year":"2017","unstructured":"Ysrraelit, M. C., Fiol, M. P., Gaitan, M. I. & Correale, J. Quality of life assessment in multiple sclerosis: Different perception between patients and neurologists. Front. Neurol. 8, 729 (2017).","journal-title":"Front. Neurol."},{"key":"33500_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3805\/jjes.25.414","volume":"25","author":"A Yutaka","year":"2008","unstructured":"Yutaka, A. & Hideki, K. Large-scale survey on the quality of life (QOL) of epilepsy patients - Differences in perception between patients and their doctors. J. Jpn. Epilepsy Soc. 25, 414\u2013424 (2008).","journal-title":"J. Jpn. Epilepsy Soc."},{"key":"33500_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2288-11-57","volume":"11","author":"JA Sacrist\u00e1n","year":"2011","unstructured":"Sacrist\u00e1n, J. A. Exploratory trials, confirmatory observations: A new reasoning model in the era of patient-centered medicine. BMC Med. Res. Methodol. 11, 57 (2011).","journal-title":"BMC Med. Res. Methodol."},{"key":"33500_CR17","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.2174\/0929867328999210111211420","volume":"28","author":"A Landolfi","year":"2021","unstructured":"Landolfi, A. et al. Machine learning approaches in Parkinson\u2019s disease. Curr. Med. Chem. 28, 6548\u20136568 (2021).","journal-title":"Curr. Med. Chem."},{"key":"33500_CR18","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00415-019-09518-3","volume":"268","author":"UK Patel","year":"2021","unstructured":"Patel, U. K. et al. Artificial intelligence as an emerging technology in the current care of neurological disorders. J. Neurol. 268, 1623\u20131642 (2021).","journal-title":"J. Neurol."},{"key":"33500_CR19","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/jamia\/ocaa194","volume":"27","author":"V Bari","year":"2020","unstructured":"Bari, V. et al. An approach to predicting patient experience through machine learning and social network analysis. J. Am. Med. Inform. Assoc. 27, 1834\u20131843 (2020).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"33500_CR20","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1109\/JBHI.2020.3038194","volume":"25","author":"N Liu","year":"2021","unstructured":"Liu, N., Kumara, S. & Reich, E. Gaining insights into patient satisfaction through interpretable machine learning. IEEE J. Biomed. Health Inform. 25, 2215\u20132226 (2021).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"33500_CR21","doi-asserted-by":"publisher","first-page":"e0000651","DOI":"10.1371\/journal.pdig.0000651","volume":"3","author":"JL Cross","year":"2024","unstructured":"Cross, J. L., Choma, M. A. & Onofrey, J. A. Bias in medical AI: Implications for clinical decision-making. PLOS Digit. Health 3, e0000651 (2024).","journal-title":"PLOS Digit. Health"},{"key":"33500_CR22","doi-asserted-by":"publisher","first-page":"e0000810","DOI":"10.1371\/journal.pdig.0000810","volume":"4","author":"EB Weiner","year":"2025","unstructured":"Weiner, E. B., Dankwa-Mullan, I., Nelson, W. A. & Hassanpour, S. Ethical challenges and evolving strategies in the integration of artificial intelligence into clinical practice. PLOS Digit. Health 4, e0000810 (2025).","journal-title":"PLOS Digit. Health"},{"key":"33500_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/PPA.S291485","volume":"15","author":"E Neter","year":"2021","unstructured":"Neter, E., Glass-Marmor, L., Haiien, L. & Miller, A. Concordance between persons with multiple sclerosis and treating physician on medication effects and health status. Patient Prefer Adherence 15, 939\u2013943 (2021).","journal-title":"Patient Prefer Adherence"},{"key":"33500_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pec.2009.09.034","volume":"80","author":"L Kriston","year":"2010","unstructured":"Kriston, L. et al. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ. Couns. 80, 94\u201399 (2010).","journal-title":"Patient Educ. Couns."},{"key":"33500_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R. & Hyman, N. The Parkinson\u2019s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson\u2019s disease summary index score. Age Ageing 26, 353\u2013357 (1997).","journal-title":"Age Ageing"},{"key":"33500_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"33500_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: Onset, progression and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"},{"key":"33500_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF02260859","volume":"4","author":"BG Vickrey","year":"1995","unstructured":"Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W. & Ellison, G. W. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 4, 187\u2013206 (1995).","journal-title":"Qual. Life Res."},{"key":"33500_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444\u20131452 (1983).","journal-title":"Neurology"},{"key":"33500_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S1525-5050(03)00004-0","volume":"4","author":"JA Cramer","year":"2003","unstructured":"Cramer, J. A. & Van Hamm\u00e9e, G. Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav. 4, 118\u2013123 (2003).","journal-title":"Epilepsy Behav."},{"key":"33500_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0149-7189(83)90005-8","volume":"6","author":"JE Ware Jr","year":"1983","unstructured":"Ware, J. E. Jr., Snyder, M. K., Wright, W. R. & Davies, A. R. Defining and measuring patient satisfaction with medical care. Eval. Program. Plann. 6, 247\u2013263 (1983).","journal-title":"Eval. Program. Plann."},{"key":"33500_CR32","unstructured":"Patient ALS partner. SDM-Q-9 \/ SDM-Q-Doc. https:\/\/www.patient-als-partner.de\/index.php?article_id=20&clang=2 (2024)."},{"key":"33500_CR33","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney, F. I. & Barthel, D. W. Functional evaluation: The Barthel index. Md. State Med. J. 14, 61\u201365 (1965).","journal-title":"Md. State Med. J."},{"key":"33500_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware, J. E. Jr. & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473\u2013483 (1992).","journal-title":"Med. Care"},{"key":"33500_CR35","unstructured":"Mao, A., Mohri, M. & Zhong, Y. In Proceedings of the 40th International Conference on Machine Learning Vol. 202 Article 992 (JMLR.org, Honolulu, Hawaii, USA, 2023)."},{"key":"33500_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco, D. & Jurman, G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genom. 21, 6 (2020).","journal-title":"BMC Genom."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33500-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33500-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33500-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:39:42Z","timestamp":1770633582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33500-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33500"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33500-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G.O. has received honoraria from AbbVie, Abbott, Boston Scientific, Eisai Co. Ltd., FP Pharmaceutical Corporation, Kyowa Hakko Kirin, Medtronic, Ono Pharmaceutical Co. Ltd, Sumitomo Pharma, Takeda Pharmaceuticals Co. Ltd., and Viatris. T.M. has received consulting fees from Takeda Pharmaceuticals Co. Ltd. Y.F. and M.I. are employees of Takeda Pharmaceutical Co. Ltd. Y.T., T.T., S.N., T.H., W.S., Y.H., S.U., D.K., Y.O., A.O., D.T., H.H. have no conflicts to declare. N.H. has received consulting fees from AbbVie Inc., Eisai Co. Ltd., FP Pharmaceutical Corporation, Kyowa Kirin Co. Ltd., Ono Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., and Sumitomo Pharma Co. Ltd.; lecture fees from Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., FP Pharmaceutical Corporation, Kyowa Kirin Co. Ltd., Nihon Medi-Physics Co. Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., and Takeda Pharmaceutical Co. Ltd.; honoraria from AbbVie Inc., FP Pharmaceutical Corporation, Kyowa Kirin Co. Ltd., and Novartis Pharma K.K.; and grants from Boston Scientific Corporation, Eisai Co. Ltd., Kyowa Kirin Co. Ltd., Medtronic Japan Co. Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., and Takeda Pharmaceutical Co. Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5394"}}